Charleston Laboratories, Inc.
George A. Scott Jr., JD, MBA, currently serves as the Executive VP of Corporate Affairs and Chief Legal Officer at Charleston Laboratories, Inc., overseeing all legal affairs for the company and its affiliates since January 2016. Prior experience includes roles as an attorney at Greenberg Traurig, LLP, focusing on mergers and acquisitions, securities, and corporate governance, and as an associate attorney at Womble Carlyle Sandridge & Rice LLP and Nexsen Pruet, LLC, where responsibilities similarly encompassed corporate governance and securities within various industries. Early career experience includes serving as an account executive at Goldman Sachs (Senderra Funding). George A. Scott Jr. earned a Juris Doctor from Charlotte School of Law, an MBA in Management from Wagner College, and a BA in Political Philosophy from Syracuse University.
This person is not in any teams
This person is not in any offices
Charleston Laboratories, Inc.
Charleston Laboratories, Inc is a specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting, the two most burdensome side effects related to opioid analgesics and other pain associated disease states. Charleston’s new products will address Opioid InducedNausea and Vomiting (OINV), Postoperative Induced Nausea and Vomiting (PONV), Chemotherapy Induced Nausea and Vomiting (CINV), Radiation Induced Nausea and Vomiting (RINV) and Migraine Induced Nausea and Vomiting (MINV). In addition, Charleston is developing other products without acetaminophen to reduce the potential for liver injury and formulations with abuse deterrent technologies designed to curb misuse & abuse.